Results 1 to 10 of about 43,824 (207)

Detection of SARS-CoV-2 infection in thyroid follicular cells from a COVID-19 autopsy series

open access: yesEuropean Thyroid Journal, 2023
Objective: To understand whether thyroid cells can be directly infected by the SARS-CoV-2 virus and to establish a putative correlation with the expression of the host entry machinery: ACE-2, TMPRSS2, and furin.
Sofia Macedo   +13 more
doaj   +1 more source

Skrining Potensi Essential Oil Cananga odorata dalam Penghambatannya Terhadap ACE II dan TMPRSS2 sebagai Anti Covid-19: Pendekatan In Silico

open access: yesJurnal Ilmiah Biosaintropis (Bioscience-Tropic), 2023
COVID-19 is a disease caused by viruses of the coronavirus class that are known to enter humans through the Angiotensin Coverting Enzyme (ACE II) receptor protein and transmembrane serine protease (TMPRSS 2).
Yoni Rina Bintari, Dian Novita Wulandari
doaj   +1 more source

Camostat Mesylate Versus Lopinavir/Ritonavir in Hospitalized Patients With COVID-19—Results From a Randomized, Controlled, Open Label, Platform Trial (ACOVACT)

open access: yesFrontiers in Pharmacology, 2022
Background: To date, no oral antiviral drug has proven to be beneficial in hospitalized patients with COVID-19.Methods: In this randomized, controlled, open-label, platform trial, we randomly assigned patients ≥18 years hospitalized with COVID-19 ...
M. Karolyi   +21 more
doaj   +1 more source

Optimization of East Java Propolis Extraction as Anti SARS-Cov-2 by Molecular Docking Study

open access: yesJurnal Ilmu dan Teknologi Hasil Ternak, 2022
The purpose of this research is to obtain the optimum propolis extraction method using microwave extraction so as to produce anti-SARS CoV-2 compounds. The research method used was experimental with a completely randomized factorial design consisting of ...
Sofia Aulia Hidayat   +3 more
doaj   +1 more source

The role of proteases in the invasion of SARS-CoV-2 virus into human host cells

open access: yesJournal of Current Biomedical Reports, 2021
The new coronavirus, which originally broke out in Wuhan, China, in December 2019, increase quickly around the world, causing a pandemic all over the world. The virus uses its spike protein to enter the human host cells.
Maryam Saeidi, Fatemeh Rouhollah
doaj   +1 more source

Impact of TMPRSS2 Expression, Mutation Prognostics, and Small Molecule (CD, AD, TQ, and TQFL12) Inhibition on Pan-Cancer Tumors and Susceptibility to SARS-CoV-2

open access: yesMolecules, 2022
As a cellular protease, transmembrane serine protease 2 (TMPRSS2) plays roles in various physiological and pathological processes, including cancer and viral entry, such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Jiewen Fu   +18 more
doaj   +1 more source

Growing concerns on male reproductive health amidst COVID-19 pandemic

open access: yesJournal of Family Medicine and Primary Care, 2022
Blood–testis barrier is body's innate mechanism to defend germ cells by creating a physical and immunological barrier. But some viral infections are known to evade it.
Megha Agrawal, Vikas Kumar, Gyan Vardhan
doaj   +1 more source

High Expression of ACE2 and TMPRSS2 at the Resection Margin Makes Lung Cancer Survivors Susceptible to SARS-CoV-2 With Unfavorable Prognosis

open access: yesFrontiers in Oncology, 2021
BackgroundCoronavirus disease 2019 (COVID-19) has rapidly spread worldwide. Systematic analysis of lung cancer survivors at molecular and clinical levels is warranted to understand the disease course and clinical characteristics.MethodsA single-center ...
Qianqian Wang   +31 more
doaj   +1 more source

A Pan-Cancer In Silico Analysis of the COVID-19 Internalization Protease: Transmembrane Proteaseserine-2

open access: yesFrontiers in Genetics, 2022
The new coronavirus (2019-nCoV) is an emerging pathogen that can cause severe respiratory infections in humans. It is worth noting that many of the affected COVID-19 patients have malignant tumors.
Yiming Meng   +5 more
doaj   +1 more source

Effect of bromhexine on clinical outcomes and mortality in COVID-19 patients: A randomized clinical trial [PDF]

open access: yesBioImpacts, 2020
Introduction: Bromhexine is a potential therapeutic option in COVID-19, but no data from a randomized clinical trial has been available. The present study aimed to evaluate the efficacy of bromhexine in intensive care unit (ICU) admission, mechanical ...
Khalil Ansarin   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy